Longevity Services & Practice Library
Every article, presentation, spotlight, and news item we've tagged to Longevity Services & Practice.
Showing 145–168 of 235
Is longevity ethical? A conversation the industry can’t avoid
This discussion reframes longevity from a pursuit of extreme lifespan extension toward a more grounded question: who benefits from living well longer, and under what conditions? The conversation bridges clinical evidence with ethical policy, arguing that longevity science should be evaluated by the same standards of safety, equity, and access applied to other medical fields.
Allen Law’s moonshot vision for the Longevity Century
Allen Law proposes that extending healthspan—not merely lifespan—is the central health challenge of the 21st century. The infrastructure and systems to support longer, stronger lives exist in scientific literature but remain inaccessible at scale; closing the 9.6-year gap between lifespan and healthspan requires proactive, preventive health built into daily life rather than reactive medicine.
‘We are not at consensus but we are at convergence’
The longevity field is moving from theoretical frameworks toward measurement-based clinical practice, with epigenetic clocks and multi-omics tools providing quantifiable biological age metrics that enable longitudinal tracking and personalized intervention. Precision assessment is becoming foundational to translating longevity research into actionable clinical protocols.
Biohacking market projected to top US$216 billion by 2035
The global biohacking market is projected to grow from US$38.05 billion in 2025 to US$216.68 billion by 2035, driven by consumer demand for self-tracking, personalized health optimization, and continuous sensing technologies. This expansion reflects a shift from consumer fitness gadgets toward clinical-grade diagnostics and subscription-based health management integrated into daily life.
Elitra Health launches concierge primary care program
Elitra Health launched a concierge primary care program limiting physician panels to 35 patients and offering 24/7 access, same-day appointments, and integrated preventive care coordination. The model prioritizes continuity of care and early detection through advanced diagnostics and personalized wellness planning as an alternative to volume-based primary care.
The oldest old become longevity biotech’s new map
Human Longevity, Inc. and LEV Foundation are analyzing blood samples from centenarians and supercentenarians using multi-omic analysis to identify molecular and cellular patterns associated with exceptional longevity. This approach shifts the field from theoretical prediction toward evidence grounded in individuals who demonstrate sustained resilience across the human lifespan.
Plug-and-play peptides hit longevity and wellness market
LifespanningRx has launched a plug-and-play platform enabling wellness businesses to offer peptide therapy within 24 hours without inventory management, regulatory overhead, or upfront investment. This model addresses the growing demand for personalized longevity interventions by removing operational barriers and shifting competition from the therapies themselves to seamless delivery infrastructure.
Precision Biomarkers Replace Reactive Screening
Aman Clinics has launched Cenegenics' precision health program in Qatar, marking the first physician-led longevity model in the region. The program shifts from reactive treatment to proactive assessment of aging biomarkers and metabolic risk before symptoms develop, embedding preventive medicine into mainstream clinical care.
New longevity drug SRN-901 shows 33% lifespan boost
SRN-901, a five-component oral combination therapy, demonstrated a 33% increase in median lifespan and 70% reduction in frailty progression in mice, with preserved physical function and reduced tumor incidence. The multi-pathway approach contrasts with single-target interventions, suggesting that aging requires simultaneous modulation of interconnected biological processes rather than isolated molecular manipulation.
LifespanningRx expands regenerative offering with RegenTherapy
LifespanningRx and RegenTherapy have partnered to integrate CellGen Factors—a cell signaling technology platform—into a consumer-accessible longevity program. The collaboration combines commercial infrastructure with clinical regenerative medicine expertise to deliver structured protocols for cellular recovery and performance optimization.
AI systems integration reshapes longevity beyond single biomarkers
Immorta Bio proposes that longevity optimization depends not on identifying a single aging biomarker, but on integrating thousands of biological signals through artificial intelligence, digital models, and patient-controlled data. This systems-based approach addresses a critical gap in precision medicine: the inability of isolated measurements to capture the body's interconnected complexity.
Forever Young explores the longevity revolution
A new documentary translates geroscience research into accessible language for public audiences, emphasizing that lifestyle and environmental factors—not genetic destiny—are the primary drivers of aging outcomes. This shift from genetic determinism to behavioral agency represents a critical moment in moving longevity science from laboratory to practical application.
How to live a long and healthy life, according to the ancients
Ancient Greek and Roman physicians documented longevity patterns through detailed case studies, identifying consistent behavioral practices—meal frequency, diet composition, daily movement, and recovery protocols—that correlated with extended healthspan. These observations predate modern gerontology by nearly two millennia yet align substantively with contemporary longevity research.
Rejuvenation Roundup April 2026
This April 2026 roundup surveys emerging research across multiple aging pathways: metabolic dysfunction accelerates aging in sedentary populations, enzymatic depletion drives cellular senescence in fat tissue, meal timing influences biological aging rates, and targeted interventions—from NAD+ restoration to immune mobilization via sauna—show measurable effects on muscle, cognition, and immune function in animal models.
Genomic precision medicine delays major disease by 20-30 years
Dr. Wei-Wu He, CEO of Human Longevity Inc., outlines a data-driven precision medicine platform built on genomic sequencing, multi-system phenotypic measurement, and longitudinal patient data to delay major age-related diseases by 20-30 years. The company has shifted from broad research ambitions to focused algorithmic development, now advancing collaborations that position it to scale personalized health optimization across populations.
Healthspan Over Lifespan: Italy's Validated Longevity Framework
Italy's National Health Service is developing an evidence-based framework to incorporate healthspan—years lived with preserved function—as a measurable outcome alongside life expectancy. The proposal outlines a staged adoption pathway for aging biomarkers, digital monitoring, and preventive interventions, requiring clinical utility and cost-effectiveness validation before implementation in routine care.
#382 ‒ AMA #80: Longevity optimization through strength benchmarks, VO₂ max targets, nutrition principles, brain health, supplements, GLP-1 RAs, wearables, and more
Exercise emerges as the most protective intervention for brain health across the lifespan, with specific performance benchmarks in strength and aerobic capacity serving as measurable proxies for cognitive preservation and longevity. This positions physical capacity as a foundational biomarker that integrates multiple physiological systems rather than a secondary health outcome.
Antiaging shifts upstream as cell wellness gains traction
The personal care and longevity industry is shifting from treating visible signs of aging to supporting cellular health upstream, positioning products as maintenance tools for biological function rather than cosmetic fixes. This repositioning extends the customer lifecycle while aligning consumer expectations with the biological mechanisms of aging.
Rejuvenation Roundup March 2026
This roundup summarizes March 2026 longevity research across multiple domains: mechanisms linking energy production to neurodegeneration, exercise's effect on brain aging, immunosenescence factors, organ-level aging processes, and the interconnection between microbiome composition, psychological state, and systemic aging. The findings collectively advance understanding of how interventions—from resistance training to nutritional composition to social environment—modulate the rate of age-related decline.
Longevity Research July 2026: Mechanisms Advance, Clinical Translation Lags
July 2026 research advances span intermittent fasting, calcium homeostasis, thymic regeneration, and senolytic therapies in animal models, alongside policy discussions on physical activity guidelines and cautionary evidence from a fatal NAD⁺ infusion. The month illustrates both the promise and peril of experimental longevity interventions—mechanistic progress tempered by real-world safety failures and the gap between animal findings and clinical application.
Senescent cell clearance and stem cell therapy extend lifespan 70%
A dual-therapy approach combining senescent cell clearance with mesenchymal stem cell restoration produced a 70% lifespan extension in mice, accompanied by sustained improvements in physiological function. This preclinical result demonstrates that coordinated interventions targeting cellular aging and tissue regeneration can produce measurable longevity gains.
#385 – AMA #82: Applying the tools of longevity in the real world: disease prevention, DEXA scans, artificial sweeteners, injury recovery, stability training, habit formation, protein intake and mTOR activation, and more
This AMA addresses practical applications of longevity science across disease prevention, body composition assessment, nutritional strategy, movement quality, and habit implementation. The focus is on translating evidence-based tools into sustained clinical and personal practice for extending both lifespan and healthspan.
Aging Science Stalled: Why Policy Reform Precedes Patient Access
Longevity research has advanced substantially in laboratories, but regulatory and policy frameworks have not kept pace, creating a critical bottleneck between scientific discovery and patient access. The Alliance for Longevity Initiatives is working to integrate aging science into mainstream health policy, treating healthy longevity as a national priority rather than a niche scientific interest.
Capriroso launches platform for athlete longevity
Capriroso's platform interprets biometric data across weeks and months rather than daily snapshots, helping endurance athletes recognize long-term physiological patterns and make training decisions based on cumulative stress and recovery trends. This approach addresses a gap where abundant data has not improved understanding, potentially extending athletic lifespan through sustainable training practices.